Sirs,
We read with interest the article of Jahnukainen and colleagues [1] who presented 26 patients with tubulointerstitial nephritis. Twelve patients (46%) presented bilateral anterior uveitis associated with tubulointerstitial nephritis, also known as tubulointerstitial nephritis and uveitis (TINU) syndrome. One of these 12 patients developed the uveitis prior to the nephrologic disease, in six, uveitis was diagnosed within 2 weeks of the diagnosis of nephritis, and in the remaining five between 3 and 15 months after onset of the nephrologic symptoms. Despite the diagnosis of uveitis, seven patients presented no ocular symptoms.
We followed a 14 year-old female adolescent with unremarkable personal and familial history who complained about fever and headache. The symptomatic therapy did not improve the subjective complaints, and 5 weeks later, leukocyturia, tubular proteinuria, and glucosuria ensued. Clinical examination was normal (body weight 58.5 kg, height 168 cm, blood pressure 118/ 70 mmHg, heart rate 76 beats/min); blood analysis revealed a moderate anemia (hemoglobin 107 g/L) together with thrombocytosis (platelets 573 G/L) and elevated markers of inflammation (C-reactive protein 87 mg/L, erythrocyte sedimentation rate 76 mm/h).
Acute renal failure (creatinine up to 141 μmol/L ) and persistent signs of tubular damage induced us to perform a renal biopsy, which highlighted severe acute tubulointerstitial nephritis. At that time, ophthalmological examination was normal, and the etiology of interstitial nephritis was unknown. Therapy with systemic corticosteroids was started: methylprednisolone endovenous 10 mg/kg for 3 days, followed by oral prednisolone 80 mg daily, which was tapered in the following 4 months. Nephritis rapidly improved (creatinine and urea decreased to normal values; glucosuria and tubular proteinuria disappeared, Fig. 1 ). However, 2 months later, still under high-dose systemic corticosteroids (0.5 mg/kg/d), the patient presented with pain and redness of both eyes. Ophthalmological examination revealed anterior bilateral uveitis, which was successfully treated with topical corticosteroids. TINU syndrome was first described 1975 by Dobrin and colleagues [2] . Uveitis usually follows nephritis, with a delay of 3 months on average [3] . In our case, uveitis ensued when the patient was still under systemic high-dose corticosteroids (Fig. 1) , as has been already described in the literature [4] . The very interesting report of Jahnukainen et al. [1] does not indicate whether uveitis developed during therapy with high-dose systemic corticosteroids.
TINU syndrome is a rare diagnosis, which should be suspected when a young patient presents with interstitial nephritis. As uveitis may rarely also occur during high-dose treatment with systemic corticosteroids and can be asymptomatic, regular ophthalmological follow-up is warranted in patients with tubulointerstitial nephritis. 
